PURPOSE There is a critical need for population-based prospective cohort studies because they follow individuals before the onset of disease, allowing for studies that can identify biomarkers and disease-modifying effects, and thereby contributing to systems epidemiology. PARTICIPANTS This paper describes the design and baseline characteristics of an intensively examined subpopulation of the ...

BACKGROUND Tumor-specific immunity of insulin-like growth factor-binding protein-2 (IGFBP-2) has been reported in several cancers. We aimed to assess the role of serum IGFBP-2 antibodies (IGFBP-2 Abs) in early cancer detection. PATIENTS AND METHODS Glioma and colorectal carcinoma (CRC) were used as models. Serum IGFBP-2 and IGFBP-2 Abs were measured in 260 tumor patients (145 gliomas, 45 colo...

1387-1811/$ see front matter 2012 Elsevier Inc. A doi:10.1016/j.micromeso.2012.01.010 ⇑ Corresponding author. Tel.: +86 25 83172266; fax E-mail address: [email protected] (W. Jin). Metal–organic framework (MOF) membranes have attracted great attention for their potential applications in gas and liquid separations. Recently, we have developed a novel reactive seeding (RS) method for the synthesi...

Enterobacter cloacae NAD(P)H:nitroreductase (NR; EC 1.6.99.7) catalyzes the reduction of a series of nitroaromatic compounds with steady-state bimolecular rate constants (kcat/Km) ranging from 10(4) to 10(7) M(-1) s(-1). In agreement with a previously proposed scheme of two-step four-electron reduction of nitroaromatics by NR (Koder, R. L., and Miller, A.-F. (1998) Biochim. Biophys. Acta 1387, ...

Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001; 24: 495–499 2. Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997; 75: 426–430 3. Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5-nucleotidase immunoreactivit...

Clayton, B. E. & Prunty, F. T. G. (1951). Brit. med. J . ii, 927. Constable, B. J., Harris, L. J. & Hughes, R. E. (1955). Proc. Nutr. SOC. 14, x. Eisenstein, A, B. & Shank, R. E. (1951). Proc. SOC. exp. Biol., N.Y. , 78, 619. Fish, E. W. & Harris, L. J. (1934). Phil. Trans. B, 223, 489. Harris, L. J., Bland, M. N. , Hughes, R. E. & Constable, B. J. (1953). Lancet, 264, 1021. Harris, L. J., Mill...

a meta-analysis of all major randomised clinical trials. Lancet 2002;359:189–198. 15. Lim MJ, Eagle KA, Gore JM, Anderson FA Jr, Dabbous OH, Mehta RH, Granger CB, Fox KA, Spencer FA, Goldberg RJ. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol 2005;96:917–921. 16. Alexander KP, Chen AY, Newby ...

protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849–853. 39. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836–843. 40. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V....

Androgen receptor (AR) and PI3K/AKT/mTORC1 are major survival signals that drive prostate cancer to a lethal disease. Reciprocal activation of these oncogenic pathways from negative cross talks contributes to low/limited success of pathway-selective inhibitors in curbing prostate cancer progression. We report that the antibiotic salinomycin, a cancer stem cell blocker, is a dual-acting AR and m...

Protein phosphorylation is one of the most essential post-translational modifications (PTMs), and orchestrates a variety of cellular functions and processes. Besides experimental studies, numerous computational predictors implemented in various algorithms have been developed for phosphorylation sites prediction. However, large-scale predictions of kinase-specific phosphorylation sites have not ...